Catalyst Wire Dossier Catalyst Wire Dossier

Orilissa

elagolix · AbbVie
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for Orilissa, covering 2018-07-23 to 2025-12-17. Get the full timeline:

Most recent: FDA Approved: ORILISSA — Supplemental Application (AbbVie Inc.)

See pricing